Venous thromboembolism in ischaemic stroke in Asia

Neurology Asia

Volumn 13, Issue 2, 2008, Pages 95-101

  Tan, K S ^a,c   Rashid, A R ^b   Tan, C T ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ANTICOAGULATION; ASIA; CAUCASIAN; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; HUMAN; LUNG EMBOLISM; PREVALENCE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 70349647368     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000; 85:1334-7.
2. Hirst AE, Gore I, Tanaka K, et al. Myocardial infarction and pulmonary embolism. Arch Pathol 1965; 80:365-70.
3. Nandi P, Wong KP, Wei WI, Ngan H, Ong GB. Incidence of deep vein thrombosis in Hong Kong Chinese. Br J Surg 1980; 67:251-3.
4. Lee LH, Gu KQ, Heng D. Deep vein thrombosis is not rare in Asia: The Singapore General Hospital experience. Annals Acad Med Singapore 2002; 31:761-4.
5. Mitra AK, Khoo TK, Ngan CC. Deep vein thrombosis following hip surgery for fracture of the proximal femur. Singapore Med J 1989; 30:530-4.
6. Lee FY, Chu W, Chan R, et al. Incidence of deep venous thrombosis after colorectal surgery in a Chinese population. Aust NZ J Surg 2001; 71:637-40.
7. Kumar K, Tang KK, Thomas J, Chumpon C. Is post-operative deep vein thrombosis a problem in neurosurgical patients with brain tumours in Singapore? Singapore Med J 2002: 43(7):345-9.
8. Tun M, Shuaib IL, Muhamad M, Mat Sain AH, Ressang AS. Incidence of post-operative deep vein thrombosis in general surgical patients of Hospital Universiti Sains Malaysia. Malaysian J Med Sciences 2001; 8:67-70.
9. Liew NC, Moissinac K, Gul Y. Venous thromboembolism in Asia: a critical review of its incidence. Asian J Surg 2003; 26(3):154-6.
10. Navarro J, Bitanga E, Tan KS, et al. Complications in acute stroke: A study in 10 Asian countries. Neurol Asia 2008; 13:33-9.
11. Tan SS, Venketasubramanian N, Ong PL, et al. Early deep vein thrombosis: Incidence in Asian Stroke Patients. Ann Acad Med Singapore 2007; 36:815-20.
12. de Silva DA, Pey HB, Wong MC, et al. Deep venous thrombosis following ischaemic stroke among Asians. Cerebrovasc Dis. 2006; 22:245-50.
13. Sun KK, Wang C, Pang BS, et al. Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25(12):1019-23.
14. Sun KK, Wang C, Pang BS, et al. The prevalence of deep venous thrombosis in hospitalized patients with stroke. Zhonghua Yi Xue Za Zhi 2004; 84(8):637-41.
15. Tongiputn S, Kunanusont S, Senjuntichai C, et al. Lower extremity deep vein thrombosis among Thai patients with stroke. Neurol J Southeast Asia 1999; 4:13-8.
16. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both or neither among 19435 patient with acute ischaemic stroke. Lancet 1997; 349:1569-81.
17. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet 1997; 349:1641-9.
18. Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995; 333:1588-93.
19. Tso SC. Deep vein thrombosis after stroke in Chinese. Aust NZ J Med 1980; 10:513-4.
20. Kelly J, Rudd A, Lewis RR, et al. Venous thromboembolism after acute ischaemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004; 35(10):2320-5.
21. The Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid) and outcome after acute ischemic stroke. JAMA 1998; 279:1265-72.
22. Hommel M for the FISS bis Investigators Group. Fraxiparine ischaemic stroke study (FISS bis). Cerebrovasc Dis 1998; 8:19 (Abstract)
23. Kwiecinski H, Pniewski J, Kaminska A, et al. A randomized trial of fraxiparine in acute ischaemic stroke. Cerebrovasc Dis 1995; 5:234 (Abstract)
24. Pambianco G, Orchard T, Landau P. Deep vein thrombosis: Prevention in stroke patients during rehabilitation. Arch Phys Med Rehabil 1995; 76:324-30.
25. Noel P, Gregoire F, Capon A, Lehert P. Atrial Fibrillation as a risk factor for deep vein thrombosis and pulmonary emboli in stroke patients. Stroke 1991; 22:760-2.
26. Oczkowski WJ, Ginsberg JS, Shin A, Panju A. Venous Thromboembolism in patients undergoing rehabilitation for stroke. Arch Phys Med Rehabil 1992; 73:712-5.
27. Elias A, Milandre L, Lagrange G, et al. Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY222) in patients with hemiplegia following cerebral infarction: a randomized pilot study(30 patients). Rev Med Interne 1990; 11:95-8.
28. Sandset PM, Dahl T, Stiris M, et al. A double blind trial and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep vein thrombosis in acute ischaemic stroke. Semin Thromb Hemost 1990; 16:25-33.
29. Prins MH, Gelsema R, Sing AK, et al. Prophylaxis of deep vein thrmobosis with a low molecular weight heparin(Kabi 2165/Fragmin) in stroke patients. Haemostasis 1989; 19:245-50.
30. Sioson ER, Crowe WE, Dawson NV. Occult proximal deep vein thrombosis: Its prevalence among patients admitted to a rehabilitation hospital Arch Phys Med Rehabil 1988;69:183-5.
31. Turpie AG, Levine MN, Hirsh J, et al. Double-blind randomised trial of deep vein thrombosis in thrombotic stroke. Lancet 1987; 1:523-6.
32. McCarthy ST, Turner JJ, Robertson D, et al. Low dose heparin as a prophylaxis against deep vein thrombosis after acute stroke. Lancet 1977; 2(8042):800-1.
33. Miyamoto AT, Miller LS. Pulmonary embolism in stroke: Prevention by early heparinization of venous thrombosis detected by iodine-125 fibrinogen leg scans. Arch. Phys. Med Rehabil 1980; 61:584-7.
34. McCarthy ST, Turner JJ, Robertson D, et al. Low dose heparin as a prophylaxis against deep vein thrombosis after acute stroke. Lancet 1977; 2(8042):800-01.
35. Gibberd FB, Gould SR, Marks P. Incidence of deep vein thrombosis and leg oedema in patients with stroke. J Neurol Neurosurg Psychiatr 1976: 39;1222-5.
36. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after stroke. BMJ 1976; 1:1178-83.
37. Cope C, Reyes T, Skversky N. Phlebographic analysis of the incidence of thrombosis in hemiplegia. Radiology 1973; 109:581-4.
38. Warlow C, Ogston D, Douglas AS. Venous thrombosis following strokes. Lancet 1972; 1:1305-6.
39. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arch Phys Med Rehabil 1992; 73:S379-91.
40. Sandercock P, Gubitz G, Foley P, et al. Antiplatelet therapy for acute ischaemic stroke (Cochrane Review) The Cochrane Library Issue 4. Article CD 000029
41. Jun ZJ, Ping T, Lei Y, et al. Prevalence of Factor V Leiden and prothrombin G2020A. mutations in Chinese patients with deep vein thrombosis and pulmonary embolism. Clin Lab Haematol 2006; 28(2):111-6.
42. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res 1997; 87(4):377-85.
43. Chen WH, Lan MY, Chang YY, et. al.The prevalence of protein C, protein S and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia. Clin Appl Thromb Hemost 2003;9(2):155-62.
44. Chen TY, Su WC, Tsao CJ. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Ann Hematol 2003; 82(2):114-7.
45. Akkawat B, Rojnuckarin P. Protein S deficiency is common in a healthy Thai population. J Med Assoc Thai 2005; 88 (Suppl 4): S249-54.
46. The European Stroke Organization Executive Committee. Guidelines for the Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. URL: http://www.eso-stroke.org/recommendations.php?cid=9 Accessed: 12th October 2008
47. National Collaborating Centre for Chronic Conditions. Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). London: Royal College of Physicians, 2008.
48. Zheng H, Liu L, Sun H, et al. Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: results from a multicenter observational longitudinal study in China. Neurol Res 2008; 30(4):370-6.
49. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital setting (ENDORSE study): a multinational cross sectional study. Lancet 2008; 371:387-94
50. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arc Phys Rehabil 1992; 73:S379-S391.
51. Mulley GP. Avoidable complications of stroke. J R Coll Physicians London. 1982; 49:279-83.
52. Noel P, Gregoire F, Capon A, Lehert P. Atrial Fibrillation as a Risk Factor for deep vein thrombosis and pulmonary emboli in stroke patients. Stroke 1991; 22:760-2.
53. Sandercock PAG, van der Belt A, Lindley R, et al. Antithrombotic therapy in acute ischaemic stroke: an overview of completed randomised trials. J Neurol Neurosurg Psychiatr 1993; 56:17-25.
54. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL): an open label randomized comparison study. Lancet 2007; 369:1347-55.
55. Counsell C, Sandercock P. Low-molecular-weight-heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. The Cochrane Database of Systematic Reviews. The Cochrane Collaboration, John Wiley & Sons Ltd, 2004
56. Hillbom M, Erila T, Sotaniemi K, et. al. Enoxaparin vs heparin for prevention of deep vein thrombosis in acute ischaemic stroke: a randomised double blind study. Acta Neurol Scand 2002; 106:84-92.
57. Bath PMW, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomized aspirin-controlled trial. Lancet 2001; 358:702-10.
58. Leonardi-Bee J, Bath F, Bath P. Comparison of low molecular weight heparin with aspirin in the treatment of acute ischaemic stroke: a systematic review. Cerebrovasc Dis 2001; 11(Suppl 4): 75.
59. Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomized study. Lancet Neurol 2007; 6:407-13.
60. Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of deep vein thromboembolism after acute ischaemic stroke. J Thromb Haemostat 2005; 3(6):1187-94.